{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:43:52Z","timestamp":1778571832965,"version":"3.51.4"},"publisher-location":"Singapore","reference-count":46,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811075711","type":"print"},{"value":"9789811075728","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-7572-8_1","type":"book-chapter","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T09:17:12Z","timestamp":1526894232000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vaccinia Virus Protein C6: A Multifunctional Interferon Antagonist"],"prefix":"10.1007","author":[{"given":"Geoffrey L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"1_CR1","volume-title":"Smallpox and its eradication","author":"F Fenner","year":"1988","unstructured":"Fenner F, Anderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organization, Geneva"},{"key":"1_CR2","volume-title":"Jenner\u2019s smallpox vaccine The riddle of the origin of vaccinia virus","author":"D Baxby","year":"1981","unstructured":"Baxby D (1981) Jenner\u2019s smallpox vaccine The riddle of the origin of vaccinia virus. Heinemann, London"},{"key":"1_CR3","volume-title":"The Orthopoxviruses","author":"F Fenner","year":"1989","unstructured":"Fenner F, Wittek R, Dumbell KR (1989) The Orthopoxviruses. Academic Press Ltd, London"},{"issue":"247\u2013266","key":"1_CR4","first-page":"263","volume":"179","author":"SJ Goebel","year":"1990","unstructured":"Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, Paoletti E (1990) The complete DNA sequence of vaccinia virus. Virology 179(247\u2013266):263\u2013517","journal-title":"Virology"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1099\/vir.0.19565-0","volume":"85","author":"C Gubser","year":"2004","unstructured":"Gubser C, Hue S, Kellam P, Smith GL (2004) Poxvirus genomes: a phylogenetic analysis. J Gen Virol 85:105\u2013117","journal-title":"J Gen Virol"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.1128\/JVI.77.13.7590-7600.2003","volume":"77","author":"C Upton","year":"2003","unstructured":"Upton C, Slack S, Hunter AL, Ehlers A, Roper RL (2003) Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. J Virol 77:7590\u20137600","journal-title":"J Virol"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1099\/vir.0.055921-0","volume":"94","author":"GL Smith","year":"2013","unstructured":"Smith GL, Benfield CT, Maluquer de Motes C, Mazzon M, Ember SW, Ferguson BJ, Sumner RP (2013) Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 94:2367\u20132392","journal-title":"J Gen Virol"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2017.03.015","volume":"186","author":"DL Veyer","year":"2017","unstructured":"Veyer DL, Carrara G, Maluquer de Motes C, Smith GL (2017) Vaccinia virus evasion of regulated cell death. Immunol Lett 186:68\u201380","journal-title":"Immunol Lett"},{"key":"1_CR9","doi-asserted-by":"crossref","unstructured":"Smith GL, Talbot-Cooper C, Lu Y (2018) How does vaccinia virus interfere with interferon? Adv Virus Res 100:355\u2013378","DOI":"10.1016\/bs.aivir.2018.01.003"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri845","volume":"2","author":"GL Smith","year":"2002","unstructured":"Smith GL, McFadden G (2002) Smallpox: anything to declare? Nat Rev Immunol 2:521\u2013527","journal-title":"Nat Rev Immunol"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","volume":"202","author":"S Pestka","year":"2004","unstructured":"Pestka S, Krause CD, Walter MR (2004) Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202:8\u201332","journal-title":"Immunol Rev"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375\u2013386","journal-title":"Nat Rev Immunol"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev.iy.11.040193.003035","volume":"11","author":"MA Farrar","year":"1993","unstructured":"Farrar MA, Schreiber RD (1993) The molecular cell biology of interferon-g and its receptor. Annu Rev Immunol 11:571\u2013611","journal-title":"Annu Rev Immunol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1101\/sqb.1998.63.609","volume":"63","author":"T Maniatis","year":"1998","unstructured":"Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG (1998) Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol 63:609\u2013620","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/0092-8674(95)90136-1","volume":"83","author":"D Thanos","year":"1995","unstructured":"Thanos D, Maniatis T (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83:1091\u20131100","journal-title":"Cell"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.83391-0","volume":"89","author":"RE Randall","year":"2008","unstructured":"Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1\u201347","journal-title":"J Gen Virol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"e1002247","DOI":"10.1371\/journal.ppat.1002247","volume":"7","author":"L Unterholzner","year":"2011","unstructured":"Unterholzner L, Sumner RP, Baran M, Ren H, Mansur DS, Bourke NM, Randow F, Smith GL, Bowie AG (2011) Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 7:e1002247","journal-title":"PLoS Pathog"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1099\/0022-1317-72-6-1349","volume":"72","author":"GL Smith","year":"1991","unstructured":"Smith GL, Chan YS, Howard ST (1991) Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J Gen Virol 72:1349\u20131376","journal-title":"J Gen Virol"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1743-422X-7-59","volume":"7","author":"JM Gonzalez","year":"2010","unstructured":"Gonzalez JM, Esteban M (2010) A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol J 7:59","journal-title":"Virol J"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1110\/ps.062454707","volume":"16","author":"M Aoyagi","year":"2007","unstructured":"Aoyagi M, Zhai D, Jin C, Aleshin AE, Stec B, Reed JC, Liddington RC (2007) Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci 16:118\u2013124","journal-title":"Protein Sci"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1099\/vir.0.82772-0","volume":"88","author":"S Cooray","year":"2007","unstructured":"Cooray S, Bahar MW, Abrescia NG, McVey CE, Bartlett NW, Chen RA, Stuart DI, Grimes JM, Smith GL (2007) Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 88:1656\u20131666","journal-title":"J Gen Virol"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"e1000128","DOI":"10.1371\/journal.ppat.1000128","volume":"4","author":"SC Graham","year":"2008","unstructured":"Graham SC, Bahar MW, Cooray S, Chen RA, Whalen DM, Abrescia NG, Alderton D, Owens RJ, Stuart DI, Smith GL et al (2008) Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog 4:e1000128","journal-title":"PLoS Pathog"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jmb.2008.09.048","volume":"385","author":"AP Kalverda","year":"2009","unstructured":"Kalverda AP, Thompson GS, Vogel A, Schroder M, Bowie AG, Khan AR, Homans SW (2009) Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J Mol Biol 385:843\u2013853","journal-title":"J Mol Biol"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"e1006079","DOI":"10.1371\/journal.ppat.1006079","volume":"12","author":"S Fedosyuk","year":"2016","unstructured":"Fedosyuk S, Bezerra GA, Radakovics K, Smith TK, Sammito M, Bobik N, Round A, Ten Eyck LF, Djinovic-Carugo K, Uson I et al (2016) Vaccinia virus immunomodulator A46: a lipid and protein-binding scaffold for sequestering host TIR-domain proteins. PLoS Pathog 12:e1006079","journal-title":"PLoS Pathog"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1074\/jbc.M113.512756","volume":"289","author":"S Fedosyuk","year":"2014","unstructured":"Fedosyuk S, Grishkovskaya I, de Almeida Ribeiro E, Skern T (2014) Characterization and structure of the vaccinia virus NF-kappaB antagonist A46. J Biol Chem 289:3749\u20133762","journal-title":"J Biol Chem"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/cdd.2008.83","volume":"15","author":"M Kvansakul","year":"2008","unstructured":"Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF, Perugini MA, Huang DC, Colman PM (2008) Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 15:1564\u20131571","journal-title":"Cell Death Differ"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"5991","DOI":"10.1074\/jbc.M114.624650","volume":"290","author":"S Neidel","year":"2015","unstructured":"Neidel S, Maluquer de Motes C, Mansur DS, Strnadova P, Smith GL, Graham SC (2015) Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family. J Biol Chem 290:5991\u20136002","journal-title":"J Biol Chem"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0092-8674(92)90274-G","volume":"71","author":"A Alcami","year":"1992","unstructured":"Alcami A, Smith GL (1992) A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153\u2013167","journal-title":"Cell"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1099\/0022-1317-71-11-2761","volume":"71","author":"JD Williamson","year":"1990","unstructured":"Williamson JD, Reith RW, Jeffrey LJ, Arrand JR, Mackett M (1990) Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J Gen Virol 71:2761\u20132767","journal-title":"J Gen Virol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1099\/0022-1317-83-8-1977","volume":"83","author":"DC Tscharke","year":"2002","unstructured":"Tscharke DC, Reading PC, Smith GL (2002) Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 83:1977\u20131986","journal-title":"J Gen Virol"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1099\/0022-1317-80-10-2751","volume":"80","author":"DC Tscharke","year":"1999","unstructured":"Tscharke DC, Smith GL (1999) A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 80:2751\u20132755","journal-title":"J Gen Virol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1099\/vir.0.049700-0","volume":"94","author":"RP Sumner","year":"2013","unstructured":"Sumner RP, Ren H, Smith GL (2013) Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy. J Gen Virol 94:1121\u20131126","journal-title":"J Gen Virol"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1016\/j.vaccine.2016.08.002","volume":"34","author":"RP Sumner","year":"2016","unstructured":"Sumner RP, Ren H, Ferguson BJ, Smith GL (2016) Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators. Vaccine 34:4827\u20134834","journal-title":"Vaccine"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"e24244","DOI":"10.1371\/journal.pone.0024244","volume":"6","author":"J Garcia-Arriaza","year":"2011","unstructured":"Garcia-Arriaza J, Najera JL, Gomez CE, Tewabe N, Sorzano CO, Calandra T, Roger T, Esteban M (2011) A candidate HIV\/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses. PLoS ONE 6:e24244","journal-title":"PLoS ONE"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"e1005955","DOI":"10.1371\/journal.ppat.1005955","volume":"12","author":"JH Stuart","year":"2016","unstructured":"Stuart JH, Sumner RP, Lu Y, Snowden JS, Smith GL (2016) Vaccinia virus protein C6 inhibits type I IFN signalling in the nucleus and binds to the transactivation domain of STAT2. PLoS Pathog 12:e1005955","journal-title":"PLoS Pathog"},{"key":"1_CR36","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/JVI.69.8.4633-4639.1995","volume":"69","author":"A Alcami","year":"1995","unstructured":"Alcami A, Smith GL (1995) Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69:4633\u20134639","journal-title":"J Virol"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1006\/viro.1995.1208","volume":"208","author":"K Mossman","year":"1995","unstructured":"Mossman K, Upton C, Buller RM, McFadden G (1995) Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 208:762\u2013769","journal-title":"Virology"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1099\/0022-1317-83-8-1953","volume":"83","author":"JA Symons","year":"2002","unstructured":"Symons JA, Tscharke DC, Price N, Smith GL (2002) A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol 83:1953\u20131964","journal-title":"J Gen Virol"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1128\/JVI.74.23.11230-11239.2000","volume":"74","author":"A Alcami","year":"2000","unstructured":"Alcami A, Symons JA, Smith GL (2000) The vaccinia virus soluble alpha\/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 74:11230\u201311239","journal-title":"J Virol"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"15974","DOI":"10.1074\/jbc.270.27.15974","volume":"270","author":"OR Colamonici","year":"1995","unstructured":"Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RM (1995) Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 270:15974\u201315978","journal-title":"J Biol Chem"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1096\/fj.10-177188","volume":"25","author":"I Montanuy","year":"2011","unstructured":"Montanuy I, Alejo A, Alcami A (2011) Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses. FASEB J 25:1960\u20131971","journal-title":"FASEB J"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0092-8674(95)90076-4","volume":"81","author":"JA Symons","year":"1995","unstructured":"Symons JA, Alcami A, Smith GL (1995) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551\u2013560","journal-title":"Cell"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/jir.2007.0113","volume":"28","author":"BA Mann","year":"2008","unstructured":"Mann BA, Huang JH, Li P, Chang HC, Slee RB, O\u2019Sullivan A, Anita M, Yeh N, Klemsz MJ, Brutkiewicz RR et al (2008) Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J Interf Cytokine Res Off J Int Soc Interferon Cytokine Res 28:367\u2013380","journal-title":"J Interf Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1128\/JVI.75.7.3185-3196.2001","volume":"75","author":"P Najarro","year":"2001","unstructured":"Najarro P, Traktman P, Lewis JA (2001) Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J Virol 75:3185\u20133196","journal-title":"J Virol"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0042-6822(92)90256-O","volume":"191","author":"AH Banham","year":"1992","unstructured":"Banham AH, Smith GL (1992) Vaccinia virus gene B1R encodes a 34-kDa serine\/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology 191:803\u2013812","journal-title":"Virology"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.chom.2007.03.007","volume":"1","author":"MS Wiebe","year":"2007","unstructured":"Wiebe MS, Traktman P (2007) Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication. Cell Host Microbe 1:187\u2013197","journal-title":"Cell Host Microbe"}],"container-title":["Advances in Experimental Medicine and Biology","Infectious Diseases and Nanomedicine III"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-7572-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T05:58:34Z","timestamp":1604296714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-7572-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811075711","9789811075728"],"references-count":46,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-7572-8_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}